Calidi Biotherapeutics, Inc. (CLDI)

Price—Loading quote
CLDINYSE
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

5 annual periodsNewest to oldest
20252024202320222021
Revenue$0$0$0$45,000—
Research & development$9.7M$8.9M$13.0M$7.3M—
Operating expenses$20.2M$21.8M$29.0M$23.2M$1.8M
Operating income−$20.2M−$21.8M−$29.0M−$23.1M−$1.8M
Operating margin———−51,395.56%—
EBITDA−$18.6M−$20.2M−$28.6M−$22.9M—
EBITDA margin———−50,817.78%—
Net income−$19.9M−$22.1M−$29.2M−$25.4M$3.4M
Net profit margin———−56,504.44%—
Basic EPSper basic share-$95.20-$571.20-$3,327.36$5,740.80—
Diluted EPSper diluted share-$95.20-$571.20-$3,327.36$5,740.80—

Owners

Reported shareholders

Reference date Jun 30, 2026
Lincoln Alternative Strategies LLC · ≈35.05% of listed sharesLeftwich Scott · ≈7.04% of listed sharesGEODE CAPITAL MANAGEMENT, LLC · 5.50% of listed sharesSchoeneck James A · ≈4.06% of listed sharesHighTower Advisors, LLC · 4.01% of listed sharesJANE STREET GROUP, LLC · 2.61% of listed sharesIndependent Advisor Alliance · 2.16% of listed sharesRS CRUM INC. · 2.08% of listed sharesArax Advisory Partners · 1.79% of listed sharesPrivate Advisor Group, LLC · 1.44% of listed sharesStewart Alan R. · ≈1.39% of listed sharesVANGUARD CAPITAL MANAGEMENT LLC · 1.22% of listed sharesPoma Eric E · ≈1.20% of listed sharesBelpointe Asset Management LLC · 0.96% of listed sharesNORTHERN TRUST CORP · 0.85% of listed sharesMORGAN STANLEY · 0.64% of listed sharesRFG Advisory, LLC · 0.58% of listed sharesFarther Finance Advisors, LLC · 0.48% of listed sharesUBS Group AG · 0.38% of listed shares
≈35.05%of listed shares
Lincoln Alternative Strategies LLC730K shares · Aug 20, 2025
View holders
Top 20 reported holders of CLDI
Holder% owned
Lincoln Alternative Strategies LLC
≈35.05%730K shares
Leftwich Scott
≈7.04%146.63K shares
GEODE CAPITAL MANAGEMENT, LLC
5.50%114.55K shares
Schoeneck James A
≈4.06%84.51K shares
HighTower Advisors, LLC
4.01%83.52K shares
Camaisa Allan
—76.95K shares
JANE STREET GROUP, LLC
2.61%54.27K shares
Independent Advisor Alliance
2.16%45K shares
RS CRUM INC.
2.08%43.24K shares
Arax Advisory Partners
1.79%37.35K shares
Private Advisor Group, LLC
1.44%30K shares
Stewart Alan R.
≈1.39%28.98K shares
VANGUARD CAPITAL MANAGEMENT LLC
1.22%25.51K shares
Poma Eric E
≈1.20%25K shares
Belpointe Asset Management LLC
0.96%19.92K shares
NORTHERN TRUST CORP
0.85%17.76K shares
MORGAN STANLEY
0.64%13.24K shares
RFG Advisory, LLC
0.58%12K shares
Farther Finance Advisors, LLC
0.48%10K shares
UBS Group AG
0.38%7.88K shares

Percentages use 2.08M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.

Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.

Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys8$455.0K disclosed value
Sells (SEC code S)2$17.4K disclosed value
10 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Dec 12, 2025Form 4Camaisa AllanDirectorSellCommon Stock · indirect850$1.46$1.2K77.0K
Aug 21, 2025Form 4Schoeneck James ADirectorBuyCommon Stock75.0K$2.00$150.0K76.1K
Aug 21, 2025Form 4Schoeneck James ADirectorBuyWarrant (right to buy) · derivative75.0K——75.0K
Aug 21, 2025Form 4Poma Eric EChief Executive OfficerBuyCommon Stock25.0K$2.00$50.0K25.0K
Aug 21, 2025Form 4Poma Eric EChief Executive OfficerBuyWarrant (right to buy) · derivative25.0K——25.0K

Community posts

It’s quiet here.

No posts about CLDI yet. Start the conversation.

Write the first post